Anam Farzand | Molecular Biology | Best Researcher Award Published on 14/11/202514/11/2025 by Environmental Scientists Ms. Anam Farzand | Molecular Biology | Best Researcher Award Sultan Zainal Abidin University | Malaysia Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Ms. Anam Farzand is a dedicated molecular biology researcher and academic whose work spans advanced laboratory sciences, cancer biology, nanotechnology, obesity genetics, and infectious disease studies, with 17 citations by 17 documents, 5 documents published, and an h-index of 2 reflecting her growing scholarly impact. As a PhD scholar, her research interests integrate obesity, nutrition, genetic predisposition, and molecular mechanisms influencing metabolic disorders. She has contributed significantly to scientific literature through publications on genomics-based nutrition, syndromic obesity, food marketing influences, viral oncology, nanostructured lipid carriers, and microbial bioactive compounds. Her earlier research explored anticancer activities of wild olive extract using lipid-based nanoparticles and the biochemical impacts of dengue infection on liver function parameters, reflecting her strong foundation in experimental design and biomedical investigation. She possesses hands-on expertise in molecular techniques including PCR, ELISA, gel electrophoresis, blotting methods, cell culture, nanoparticle formulation, microscopy, and advanced analytical assessments. Her professional journey includes extensive teaching in biophysics, pathology, immunology, biotechnology, hematology, endocrinology, and related biosciences, along with experience supervising numerous undergraduate and graduate research projects. She has also facilitated academic programs in specialized health sciences, contributing to curriculum support, student mentorship, and research coordination. Her scholarly engagement extends to peer reviewing for reputable journals and contributing to scientific conferences, demonstrating her active role in academic development and quality research dissemination. With strong analytical capabilities and a passion for innovative biomedical solutions, she continues to advance research at the interface of molecular biology, clinical sciences, and translational health technologies. Profiles: Scopus | Orcid | Google Scholar | Researchgate
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).
Featured Publications Ahmed, N., Abusalah, M. A. H. A., Farzand, A., Absar, M., Yusof, N. Y., Rabaan, A. A., … (2022). Updates on Epstein–Barr Virus (EBV)-associated nasopharyngeal carcinoma: Emphasis on the latent gene products of EBV. Medicina, 59(1), 2. Ahmed, N., Abusalah, M. A. H. A., Absar, M., Nasir, M. H., Farzand, A., Ahmad, I., … (2025). The microbial sources of bioactive compounds: Potential anticancer therapeutic options. Nano LIFE, 15(04), 2430007. Iqbal, M., Farzand, A., Ahmad, I., Iqbal, S., & Mubeen, A. (2022). Comparative study of hematological profile variation in three trimesters of pregnancy: Study of hematological profile variation in pregnancy. Pakistan BioMedical Journal, 23–27. Malik, S., Awan, S. J., Farzand, A., & Ali, Q. (2022). Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat’s bone marrow cells’ lysate. Brazilian Journal of Biology, 82, e269553. Farzand, A. (2021). A review on the medicinal potential of Trachyspermum ammi found in Pakistan. Journal of Pharmaceutical Research International, 33(41B).